Aprea Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: APRE · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1781983
| Field | Detail |
|---|---|
| Company | Aprea Therapeutics, Inc. (APRE) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: APRE
TL;DR
APRE filed an 8-K for shareholder vote matters on 6/5.
AI Summary
Aprea Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 5, 2025. The company, incorporated in Delaware, is based in Doylestown, PA, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates a significant corporate event involving shareholder decisions, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Aprea Therapeutics, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
- June 9, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 215-948-4119 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this excerpt.
When did the event related to the submission of matters to a vote occur?
The earliest event reported, which is the date of the submission of matters to a vote of security holders, was June 5, 2025.
What is the principal executive office address of Aprea Therapeutics, Inc.?
The address of the principal executive offices is 3805 Old Easton Road, Doylestown, PA 18902.
What is Aprea Therapeutics, Inc.'s IRS Employer Identification Number?
Aprea Therapeutics, Inc.'s IRS Employer Identification Number is 84-2246769.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Aprea Therapeutics, Inc. (APRE).